HARBOR CAPITAL ADVISORS, INC. Kymera Therapeutics, Inc. Transaction History

HARBOR CAPITAL ADVISORS, INC. portfolio value:

$260,000
portfolio value

HARBOR CAPITAL ADVISORS, INC. quarter portfolio value change:

+10.56%
quarter

Kymera Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -2.77% -340 shares 19K $21.77 11.92K
Q2 2022 share Decrease -12.36% -1.73K shares -351K $19.69 12.26K
Q1 2022 share Decrease -16.95% -2.85K shares -478K $42.32 13.99K
Q4 2021 share Increase 0.00% 16.85K shares 1.07M $62.98 16.85K